Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T W Wiegand

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Molecular Biology|January 14, 1994
Interaction of Tn5 transposase with the transposon terminiT W Wiegand, W S Reznikoff
Journal of Bacteriology|February 1, 1992
Characterization of two hypertransposing Tn5 mutantsT W Wiegand, W S Reznikoff
Chemistry & Biology|October 23, 1997
Selection of RNA amide synthasesT W Wiegand, R C Janssen, B E Eaton
The British Journal of Ophthalmology|October 31, 2008
Intravitreal bevacizumab (Avastin) treatment of choroidal neovascularisation in patients with angioid streaksT W Wiegand, A H Rogers, F McCabe, et al.
Journal of Bacteriology|November 1, 1993
Characterization of the Tn5 transposase and inhibitor proteins: a model for the inhibition of transpositionN B de la Cruz, M D Weinreich, T W Wiegand, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1996
High-affinity oligonucleotide ligands to human IgE inhibit binding to Fc epsilon receptor IT W Wiegand, P B Williams, S C Dreskin, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Molecular Biology|January 14, 1994
Interaction of Tn5 transposase with the transposon terminiT W Wiegand, W S Reznikoff
Journal of Bacteriology|February 1, 1992
Characterization of two hypertransposing Tn5 mutantsT W Wiegand, W S Reznikoff
Chemistry & Biology|October 23, 1997
Selection of RNA amide synthasesT W Wiegand, R C Janssen, B E Eaton
The British Journal of Ophthalmology|October 31, 2008
Intravitreal bevacizumab (Avastin) treatment of choroidal neovascularisation in patients with angioid streaksT W Wiegand, A H Rogers, F McCabe, et al.
Journal of Bacteriology|November 1, 1993
Characterization of the Tn5 transposase and inhibitor proteins: a model for the inhibition of transpositionN B de la Cruz, M D Weinreich, T W Wiegand, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1996
High-affinity oligonucleotide ligands to human IgE inhibit binding to Fc epsilon receptor IT W Wiegand, P B Williams, S C Dreskin, et al.
Pageof 1